BAM
APLS icon

Belpointe Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History

Belpointe Asset Management’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-224
Closed -$14.8K – 738
2023
Q1 		$14.8K Buy
+224
New +$14.8K ﹤0.01% 2487